mRNA |
CAY10576 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
0.034 |
0.6 |
mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
Nilotinib |
FIMM |
pan-cancer |
AAC |
0.1 |
0.6 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
TPCA-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |